Fibroblasts at the wound site are recognized as the primary drivers of scar formation. They differentiate into myofibroblasts, the key mediators of fibrosis, which are responsible for collagen deposition and wound contraction. Repair processes cease when epithelialization is completed in normal wounds, whereas in keloid wounds, they may continue and result in excessive accumulation of unorganized extracellular matrix, forming problematic scars.
In addition to resident mesenchymal cells, fibroblasts and myofibroblasts are thought to be derived from multiple sources, including epithelial-mesenchymal transition (EMT) [1]. During this process, epithelial cells experience intercellular and intracellular changes, including dissociation of junctional complexes, loss of apical-basolateral polarity, and repression of epithelial markers. As a result, epithelial cells lose many of their properties and take on characteristics of mesenchymal cells.
To investigate this process, an immunofluorescence assay using both epithelial and mesenchymal markers was performed using keloid tissues obtained from the anterior chest wall of a 70-year-old male patient (Fig. 1). After fixation, cells were incubated with primary antibodies against E-cadherin and vimentin (Abcam, Cambridge, UK), and subsequently labelled with fluorescently-tagged secondary antibodies. Counterstaining with 4’,6-diamidino-2-phenylindole (DAPI) (VECTOR Laboratories, Burlingame, CA, USA) was also performed.
Cells were visualized using an LSM 700 Carl Zeiss confocal microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA). E-cadherin and vimentin expression were simultaneously observed at the dermo-epidermal junction in keloid tissue, indicating the occurrence of EMT (Fig. 2).
Although further investigations with additional keloid specimens are needed, we hope that our study yields some insight into the mechanisms of keloid formation.
